Insurtech Distribution vs Becoming a Carrier: Which First?
Start as a managing general agent (MGA) or distribution platform: it's capital-light, fast to launch, and lets a licensed carrier absorb underwriting risk while you own the customer relationship and the data. Move toward becoming a carrier only once volume and margin pressure make owning that risk worth the capital and regulatory burden full licensure demands.
Quick Answer: Launch as a distribution player or MGA — capital-light, fast, and backed by a carrier's paper — to validate the product first. Pursue your own carrier license only once scale, loss experience, and margin economics justify the capital and regulatory commitment; most insurtechs that get there arrive via a hybrid path, not a straight jump.
Before weighing distribution against becoming a carrier, a more basic question comes first: have you actually established that people want the insurance product you're planning to build around? If you haven't tested that yet, How to Validate an Insurtech Startup Idea is the place to start — distribution vs. carrier is a cost-and-capital-structure decision, and structure decisions only matter once demand is real. This piece assumes you're past that point and are now weighing how to actually deliver the regulated product.
The fork itself will look familiar if you've spent time in fintech: it's the insurance-industry version of Bank Partnership vs Your Own License: Which Path First? — rent someone else's balance sheet and regulatory standing to move fast, or build your own and own the economics along with the liability. One caveat before the comparison: insurance licensing, capital, and solvency requirements vary by state, by line of business, and by structure (MGA, program administrator, fronting arrangement, admitted vs. non-admitted paper), and they change over time. Nothing here is a substitute for insurance counsel or a specialist managing general underwriter (MGU) consultant who can tell you what actually applies to your product and the states you operate in. Treat this as a framework for the decision, not a citation of the rules themselves.
Both paths get you to the same place — a policyholder holding coverage with your brand on the experience — but on completely different cost, timeline, and control profiles. Neither is objectively better. The right one depends on your stage and which constraint is actually binding on your business right now.
Capital, Licensing, Margin, and Control, Side by Side
The two paths trade off against each other on almost every dimension an early-stage insurtech founder cares about, which is exactly why there's no universal right answer — only a right answer for your stage and your constraint. The table below lines up the variables that most often drive the decision.
| Dimension | Distribution / MGA | Full Carrier |
|---|---|---|
| Upfront capital | Low relative to chartering a carrier — mostly licensing, compliance staffing, and technology, not risk capital | High — statutory capital and surplus requirements, reserve funding, and a compliance build-out before you can bind a single policy |
| Licensing path | Producer/agency and MGA licensing in the states you operate, generally faster to obtain | Certificate of authority as an admitted (or approved surplus lines) carrier in each state you write in — a materially longer, more document-heavy process |
| Underwriting risk | Sits with the carrier(s) whose paper you distribute on; you earn commission and fee income, not underwriting profit | Sits entirely with you — you set the price, you carry the loss ratio, and you keep, or lose, the underwriting margin |
| Margin / economics | Commission- and fee-based, capped by what carrier partners will pay for distribution and any delegated authority | Structurally better once volume and loss experience are favorable enough to price and reserve profitably at scale |
| Product control | Bounded by what your carrier partner(s) will approve — coverage terms, pricing bands, and appetite | Full control over product design, pricing, and terms, within what regulators generally allow |
| Time to first policy sold | Fastest available path — you can often bind business on an existing carrier's paper within months | Slowest path — licensing and capital build-out is commonly measured in years, not months |
| Regulatory / solvency risk | Shared — the carrier carries the primary regulatory relationship and solvency obligation | Fully yours — you carry the regulatory relationship, reserve adequacy, and the liability if pricing or reserving goes wrong |
Read the table as a trade of speed and low fixed cost against ownership of the underwriting economics. Distribution gets a product in front of policyholders fastest, with a carrier partner standing behind every claim. Becoming a carrier reverses that: slower and far more capital-intensive to reach that first bound policy, but nothing standing between your pricing and underwriting decisions and the margin they produce once you're properly licensed and reserved.
When Distribution or an MGA Is the Right Start
Choose distribution — or step up to a full managing general agent arrangement with delegated underwriting authority — when speed to market and capital efficiency matter more than owning the underwriting economics, which describes almost every insurtech before the product is proven.
Distribution or an MGA structure is the right starting point when you're in one or more of these situations:
- You haven't validated demand for the specific product yet, and committing years and significant capital to a carrier license before that's answered is the wrong order of operations.
- You're testing more than one insurance product or niche. Distribution lets you launch, learn, and pivot to a different line without stranding a large regulatory investment on the one that didn't work.
- Your team doesn't have deep actuarial or reserving expertise yet. A carrier partner's existing pricing, reserving, and compliance functions cover gaps a small early team can't credibly staff on its own.
- You need to preserve runway for product and distribution, not for a licensing application and the capital infrastructure a carrier license requires you to build and maintain.
- You're not yet certain which states or lines you'll ultimately focus on. Some carrier partners will help you narrow that as part of onboarding, which is cheaper than committing capital to the wrong scope on your own.
The tradeoff compounds the longer you stay purely on distribution: commission and fee income is real revenue, but it's a smaller slice of the premium dollar than owning the underwriting margin, and every product change that touches coverage or pricing needs a carrier partner's sign-off first. Before you commit to distribution as more than a starting point, run a full competitor analysis on your niche. A market already served by several MGAs distributing similar paper from the same handful of carriers is a commodity position you'll eventually get priced out of; a genuinely underserved niche is where delegated underwriting authority — and eventually your own paper — actually pays off.
When a Full Carrier Makes Sense
Pursue a carrier license once distribution's constraints are actively capping the business you're trying to run, not as a default ambition. Three signals tend to show up together when that point arrives: your commission economics are structurally capped at a volume where owning the underwriting margin would clearly be worth more; carrier partners keep declining to write products or terms that are core to your differentiation; and dependence on one or two carriers' capacity has become a real business risk rather than a hypothetical one.
Pursuing your own carrier license is worth the investment when:
- Volume and loss experience already justify the fixed cost. You have enough premium volume and mature-enough loss data that the ongoing cost of capital and compliance infrastructure is smaller than what you're currently giving up in commission share.
- A specific coverage or pricing requirement keeps getting declined. You've hit a real, recurring wall where carrier partners won't support a term core to your differentiation, not a one-off request.
- Carrier concentration risk is now a board-level concern, because the business would be materially damaged if a capacity provider pulled out or exited the line.
- You're building proprietary underwriting data or models that are worth more as risk you hold yourself than as a service you sell to someone else's carrier.
- You have, or can raise, the multi-year capital a licensing and reserve build-out requires without starving the rest of the business of resources it needs while you wait.
None of that is a fast or cheap decision, and it shouldn't be treated as one. Becoming a carrier means owning statutory capital requirements, the actuarial and reserving function, and the direct regulatory relationship in every state you write in — liability that used to sit with your carrier partner now sits with you. That's the entire point of doing it: underwriting margin flows to whoever carries the risk. It only pays off once you're operating at a scale, and with loss data mature enough, to price and reserve that risk responsibly.
Hybrid — MGA Now, Carrier Later
The realistic path for most insurtechs isn't a single, permanent choice — it's starting on delegated underwriting authority as an MGA and deliberately building toward carrier status, or a reinsurance-backed structure, once the business earns it.
In practice, that usually runs through a fronting carrier: you underwrite and distribute the product under a carrier's license and paper, then increasingly take on the underwriting economics yourself through quota-share reinsurance or a captive reinsurer as your loss data matures and your balance sheet can support it. That structure lets you capture more of the underwriting margin over time without needing a full admitted-carrier license on day one — though a captive or reinsurance vehicle still carries its own capital and regulatory requirements, which is a conversation for insurance counsel and a reinsurance broker, not something to structure from a general framework.
Start that transition well before distribution's limits are actually blocking growth. Capital raises, fronting agreements, and reinsurance structures all take longer to put in place than founders expect, so waiting until you're desperate leaves you stuck on unfavorable partner terms for longer than necessary. Run the transition in parallel with the operating business rather than pausing to pursue it: keep binding business on the existing fronting relationship while the new structure gets built, and migrate deliberately once it's ready rather than switching overnight.
The other half of the hybrid path is choosing the right fronting carrier and reinsurance partners in the first place, because not every capacity provider is equally good to build a multi-year program on top of. A partner that pulls capacity, repriced terms unilaterally, or exits the line disrupts your business with limited warning — exactly the continuity risk a hybrid strategy is supposed to manage down, not recreate under a different name on the contract.
Key Takeaways
- Speed and capital efficiency favor distribution; ownership of underwriting margin favors becoming a carrier. Neither path is universally correct — the right one depends on your stage and which constraint actually binds.
- Validate the insurance product before you commit to either structure. Distribution vs. carrier is a cost-and-capital decision, and those only matter once demand is proven.
- Distribution shares regulatory and solvency risk with a carrier partner; owning a license concentrates both on you. That shift in liability is the real trade, not just the commission split.
- Carrier concentration is a real business risk, not just an operational detail — a partner pulling capacity or exiting a line can disrupt operations with limited warning.
- Carrier economics only work past a volume and loss-data threshold. Below that, the fixed cost of capital and compliance outweighs the underwriting margin you'd capture by owning the risk.
- Most insurtechs follow a hybrid path — MGA and fronting first, quota-share reinsurance or a captive as data matures, full carrier status, if it happens at all, last.
- Regulatory specifics vary by state and line of business, and they change. Treat this article as a framework, and confirm the actual requirements for your product with insurance counsel.
FAQ
Is an MGA the same thing as an insurance carrier?
No. A managing general agent (MGA) underwrites, prices, and often binds policies on behalf of one or more licensed carriers, using authority the carrier delegates to it — but the carrier holds the license, the paper, and the underwriting risk. An MGA earns commission and fee income; a carrier earns, or loses, underwriting margin directly.
How much capital does it take to become a licensed insurance carrier?
Materially more than distribution requires — carriers must hold statutory capital and surplus and fund reserves before writing business, on top of the cost of the licensing process itself. Exact requirements vary too widely by state and line of business to state as a single figure; get a current number from insurance counsel or the relevant state insurance department for your specific product.
Can a distribution company or MGA become a carrier later?
Yes, and it's the common path. Most insurtechs that eventually hold their own paper get there through an MGA and fronting-carrier stage first, often adding quota-share reinsurance or a captive before pursuing full licensure. The transition takes real capital and multi-year lead time, so it's worth starting well before distribution's constraints are actually blocking growth.
Do you need an insurance license to operate a distribution platform?
Generally yes, in some form — a producer, agency, or MGA license in the states where you operate, even though you're not the risk-bearing entity. Which specific license applies depends on what your platform actually does — referring, quoting, binding, or delegated underwriting — and that's a question for insurance counsel, since requirements vary by state and by function.